{"transactions":[{"id":1619819,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93907,"kind":"person","name":"Poole Robert Michael","position":1,"cik":"0001871782","reported_name":"Poole Robert Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T18:01:37.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-003968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871782/000120919124003968/doc4.xml","form_type":"4"}},{"id":1990638,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93907,"kind":"person","name":"Poole Robert Michael","position":1,"cik":"0001871782","reported_name":"Poole Robert Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T17:01:47.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-013251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871782/000120919123013251/doc4.xml","form_type":"4"}},{"id":2411852,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93907,"kind":"person","name":"Poole Robert Michael","position":1,"cik":"0001871782","reported_name":"Poole Robert Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T20:51:56.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-007329","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871782/000120919122007329/doc4.xml","form_type":"4"}},{"id":2635036,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93907,"kind":"person","name":"Poole Robert Michael","position":1,"cik":"0001871782","reported_name":"Poole Robert Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-13T16:25:15.000Z","date":"2021-07-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 1/36th of the shares subject to the option shall vest every month after July 9, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.94,"expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-046497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871782/000120919121046497/doc4.xml","form_type":"4"}}]}